ClinicalTrialsFinder
RecruitingNot ApplicableNCT06667427

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

Sponsor

M.D. Anderson Cancer Center

Enrollment

40 participants

Start Date

Jan 13, 2025

Study Type

INTERVENTIONAL

Conditions

Head and Neck CancerCancer

Summary

The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.

Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • In order to be eligible to participate in the intervention group of this study, an individual must meet all of the following criteria:
  • Provision of signed and dated informed consent form
  • Aged 18 or greater
  • Patient scheduled to undergo facial nerve transfer
  • Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
  • In order to be eligible to participate in the non-intervention historical control group of this study, an individual must meet all of the following criteria:
  • Provision of signed and dated informed consent form
  • Aged 18 or greater
  • Previous facial surgery severing a facial nerve without graft or other form of dynamic facial nerve reconstruction within the last 20 years

Exclusion Criteria1

  • Patients known to be pregnant

Interventions

PROCEDURENerve transfer techniques

Participants will undergo facial nerve reconstruction using nerve transfer techniques

Locations(1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06667427

Related Trials

Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer

NCT061848801 location

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT074245475 locations

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

NCT053181961 location

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT055881411 location

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

NCT025071415 locations